François Giuliano mainly focuses on Erectile dysfunction, Internal medicine, Sexual dysfunction, Urology and Placebo. His study in Erectile dysfunction is interdisciplinary in nature, drawing from both Sildenafil, Tolerability and Epidemiology. His Internal medicine research incorporates elements of Endocrinology and Pharmacology.
The study incorporates disciplines such as Serotonergic and Spinal cord in addition to Endocrinology. His Sexual dysfunction research is multidisciplinary, incorporating perspectives in Evidence-based medicine, Gynecology, Sexual medicine and Clinical psychology. His studies deal with areas such as Randomized controlled trial and Clinical trial as well as Placebo.
His scientific interests lie mostly in Erectile dysfunction, Internal medicine, Urology, Endocrinology and Gynecology. His Erectile dysfunction research is multidisciplinary, relying on both Sildenafil, Placebo and Sexual function. His study in Ejaculation, Dopamine and Nephrology falls under the purview of Internal medicine.
His work carried out in the field of Urology brings together such families of science as Tadalafil, Overactive bladder, cGMP-specific phosphodiesterase type 5 and Hyperplasia. His research on Gynecology often connects related topics like Dapoxetine. His study in the field of International Prostate Symptom Score is also linked to topics like Tamsulosin and Sexual dysfunction.
François Giuliano mainly investigates Urology, Erectile dysfunction, Internal medicine, Ejaculation and Lower urinary tract symptoms. His study on Urology also encompasses disciplines like
His Internal medicine study frequently draws connections between related disciplines such as Endocrinology. His work in Ejaculation addresses issues such as Spinal cord, which are connected to fields such as Anatomy. In general Lower urinary tract symptoms study, his work on International Prostate Symptom Score often relates to the realm of Tamsulosin and Hyperplasia, thereby connecting several areas of interest.
François Giuliano spends much of his time researching Erectile dysfunction, Urology, Ejaculation, Lower urinary tract symptoms and Placebo. His Erectile dysfunction study results in a more complete grasp of Surgery. François Giuliano interconnects Sildenafil, cGMP-specific phosphodiesterase type 5 and Cyclic guanosine monophosphate in the investigation of issues within Urology.
His Ejaculation study is related to the wider topic of Internal medicine. His study in the fields of International Prostate Symptom Score under the domain of Lower urinary tract symptoms overlaps with other disciplines such as Tamsulosin. He has included themes like Dapoxetine, Randomized controlled trial and Gynecology in his Placebo study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
Raymond Rosen;Jens Altwein;Peter Boyle;Roger S Kirby.
European Urology (2003)
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.
Konstantinos Hatzimouratidis;Edouard Amar;Ian Eardley;Francois Giuliano.
European Urology (2010)
Summary of the recommendations on sexual dysfunctions in men
Francesco Montorsi;Ganesan Adaikan;Edgardo Becher;Francois Giuliano.
The Journal of Sexual Medicine (2004)
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation.
Chris G. McMahon;Stanley E. Althof;Marcel D. Waldinger;Hartmut Porst.
The Journal of Sexual Medicine (2008)
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial.
H Porst;R Rosen;H Padma-Nathan;I Goldstein.
International Journal of Impotence Research (2001)
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial
Hartmut Porst;Harin Padma-Nathan;François Giuliano;Greg Anglin.
Urology (2003)
An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation
Ege Can Serefoglu;Chris G. Mcmahon;Marcel D. Waldinger;Stanley E. Althof.
The Journal of Sexual Medicine (2014)
Neural control of penile erection.
François A. Giuliano;Olivier Rampin;Gérard Benoit;Alain Jardin.
Urologic Clinics of North America (1995)
Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy
H Padma-Nathan;A R McCullough;L A Levine;L I Lipshultz.
International Journal of Impotence Research (2008)
Development and Validation of a Premature Ejaculation Diagnostic Tool
Tara Symonds;Michael A. Perelman;Stanley Althof;François Giuliano.
European Urology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
New England Research Institutes
Tulane University
Vita-Salute San Raffaele University
Valparaiso University
Vita-Salute San Raffaele University
The University of Texas Southwestern Medical Center
Université Paris Cité
Charles University
Université Paris Cité
Swinburne University of Technology
London School of Economics and Political Science
Xi'an Jiaotong University
State University of Campinas
South Australian Museum
Scripps Institution of Oceanography
University of Eastern Finland
Institut de Recherche pour le Développement
University of Hawaii System
Huntington Medical Research Institutes
Institut Pasteur
University College London
Louisiana State University Health Sciences Center New Orleans
King's College London
Inserm : Institut national de la santé et de la recherche médicale
German Cancer Research Center
Ludwig-Maximilians-Universität München